Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms
NCT02921282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2024-03-08
Summary
In this study, potential associations between several genetic polymorphisms and nicotine dependence will be examined. The relative reinforcing efficacy of cigarettes using the forced-choice procedure will be assessed. In addition, reactivity to smoking cues using a reliable procedure will be conducted.
Conditions
- Cigarette Smoking Behavior
Interventions
- GENETIC
-
Genotype dopamine
Laboratory investigations of nicotine reinforcement
- GENETIC
-
Genotype cannabinoids
Laboratory investigations of nicotine reinforcement
Sponsors & Collaborators
-
Centre for Addiction and Mental Health
lead OTHER
Principal Investigators
-
Bernard Le Foll, MD PhD · CAMH
Eligibility
- Min Age
- 19 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2019-11-29
- Completion
- 2019-11-29
Countries
- Canada
Study Locations
More Related Trials
-
Acute and Chronic Nicotine Modulation of Reinforcement Learning
NCT01830842 ·Status: COMPLETED ·Phase: NA
-
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
NCT01928758 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetics, Emotional Reactivity and Smoking
NCT00507728 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Genetically Informed Smoking Cessation Trial
NCT02351167 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 ·Status: COMPLETED ·Phase: NA
-
Behavioral Pharmacology of Cannabis and Nicotine
NCT04124432 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Metabolites in Nicotine Dependence (4) - 13
NCT00000296 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nicotine in Tobacco Smokers
NCT03651869 ·Status: COMPLETED ·Phase: PHASE1
-
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
NCT01055886 ·Status: COMPLETED ·Phase: NA
-
Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes
NCT00622752 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers
NCT01429129 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
NCT01406223 ·Status: COMPLETED ·Phase: PHASE3
-
Extinction Based Treatment for Nicotine Dependence
NCT00831155 ·Status: COMPLETED ·Phase: PHASE1
-
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
NCT03960138 ·Status: COMPLETED ·Phase: NA
-
Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
NCT02551692 ·Status: COMPLETED ·Phase: NA
-
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
NCT00129246 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients
NCT03272295 ·Status: COMPLETED ·Phase: NA
-
Effects of Smoking Environments on Brain Reactivity
NCT03421210 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
NCT00330187 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
NCT02906644 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
NCT05587361 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Non-invasive Brain Stimulation in Tobacco Use Disorder
NCT02776319 ·Status: UNKNOWN ·Phase: NA